[{"Year":"2007","Value":94.1,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2008","Value":95.3,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2009","Value":95.4,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2010","Value":96.5,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2011","Value":95.1,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2012","Value":96.2,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2013","Value":96.9,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2014","Value":95.8,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2015","Value":96.6,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2016","Value":96.1,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2017","Value":93.4,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2018","Value":94.5,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2019","Value":94.351083,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2007","Value":98.8,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2008","Value":99.1,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2009","Value":98.9,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2010","Value":98.3,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2011","Value":97.2,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2012","Value":97.7,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2013","Value":98.666102,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2014","Value":95.6,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2015","Value":99.1,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2016","Value":97.0,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2017","Value":94.7,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2018","Value":96.244215,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2019","Value":97.245414,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2015","Value":96.8,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2016","Value":97.2,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2017","Value":94.2,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2018","Value":92.0,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2019","Value":95.083643,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"}]